Immune modulation for β-cell replacement in type 1 diabetes
Type 1 diabetes (T1D) is driven by autoimmune destruction of pancreatic β-cells and remains incurable despite major advances in insulin delivery and glucose-monitoring technologies. Transplantation of primary islets or stem cell-derived β-like cells offers a promising route to physiological glycemic...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2026-04-01
|
| Col·lecció: | Frontiers in Immunology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1785523/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|